ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apot...

FDA Recall #D-0112-2021 — Class II — November 17, 2020

Recall #D-0112-2021 Date: November 17, 2020 Classification: Class II Status: Terminated

Product Description

ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

Reason for Recall

FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets

Recalling Firm

Golden State Medical Supply Inc. — Camarillo, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

11,922 bottles

Distribution

Distributed Nationwide in the USA

Code Information

Lot #: GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated